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Background: Sepsis causes neutrophil sequestration in the lung which leads to acute lung injury (ALI). Radix
Ginseng (RG), a traditional herb used as herbal remedy in eastern Asia for thousands of years, which has been
traditionally used in China to improve blood circulation and ameliorate pathological hemostasis. This study
investigated whether Ginsenoside Rb1, the main components of RG, can attenuate ALI induced by LPS.
Methods: In vivo, 30 male Wistar rats were divided into three groups (n = 10 each groups) on the basis of the
reagent used, which were subjected to LPS injection with or without Ginsenoside Rb1 (5 mg/kg) treatments to
induce ALI model. Lung injury was assessed by pulmonary histology, lung wet-weight to dry-weight (W/D) ratio,
the number of myeloperoxidase (MPO) positive cells, immunohistochemical analysis of intercellular adhesion
molecule-1 (ICAM-1), gene expression of ICAM-1, ultrastructure changes of pulmonary microvasculature, concentration
of inflammatory markers and in plasma. In vitro, pulmonary microvascular endothelial cells (PMVECs) were stimulated
with LPS in the presence and absence of Ginsenoside Rb1 (50 mM), nuclear factor-κB (NF-κB) p65 was measured by
immunocytochemistry staining and western blotting.
Results: Infusion of LPS induced lung injury, in vivo, as demonstrated by pulmonary edema with infiltration of
neutrophils and hemorrhage, the increase in lung W/D ratio, the number of MPO positive cells, the level of
inflammatory markers such as TNF-α, MCP-1 and IL-8, enhanced expression of ICAM-1 and ICAM-1 gene. Moreover,
resulted in the changes of intercellular junctions in the endothelial cells of pulmonary microvasculature. In vitro, the
significant increased release of NF-κB p65 and its subsequent translocation into the nucleus in PMVECs were observed.
In contrast, Ginsenoside Rb1 treatment significantly ameliorated the LPS-induced lung injury, as judged by the marked
improvement in all these indices.
Conclusions: These results indicate that Ginsenoside Rb1 attenuated LPS-induced lung injury through an inhibition of
the inflammatory signaling pathway, besides the direct inhibitory effect on proinflammatory molecules.
Keywords: Acute lung injury, ICAM-1, Ginsenoside Rb1, MPO, NF-κB P65, LPSIntroduction
Acute lung injury (ALI) and acute respiratory distress syn-
drome (ARDS) in their most severe forms are still major
challenges in modern intensive care medicine that signifi-
cantly contribute to morbidity and mortality of critically ill
patients. A recent epidemiological study indicate that ALI
leads to 75,000 deaths annually in the United States [1].
Respiratory failure is caused by an excessive inflammatory
response to both pulmonary and extrapulmonary stimuli,* Correspondence: Leipan61@aliyun.com
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unless otherwise stated.including pneumonia, acid aspiration, ischemia-reperfusion
and sepsis [2]. Inflammatory mediators can disrupt the pul-
monary capillary barrier, leading to the influx of a protein-
rich edema with severe consequences for gas exchange and
the functional integrity of remote organ systems [3]. Exces-
sive infiltration of polymorphonuclear leukocytes (PMNs)
into the lungs has been identified as a pivotal event in the
early development of ALI.
Pulmonary microvascular endothelial cells(PMVECs)
are critically involved in the pathogenesis of acute lung in-
jury. PMVECs can be stimulated by pro-inflammatory cy-
tokines including TNF-α to express adhesion molecules
such as intercellular cell adhesion molecule-1 (ICAM-1)d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pression of adhesion molecules on PMVECs leads to
leukocyte recruitment via interactions with their cognate
ligands on leukocytes at the sites of atherosclerosis.
PMVECs play an important role in initiation and develop-
ment of pulmonary inflammation procedure as well as
early target cells [4].
Radix Ginseng (RG), a traditional used as a herbal rem-
edy in eastern Asia for thousands of years, which has been
traditionally used in China to improve blood circulation
and ameliorate pathological hemostasis and has also re-
cently become popular in Western countries. Recently, it
was reported that there are some active compounds in RG
which could scavenge radical, inhibit the leukocytes
adhesion to venular wall or protect lipopolysaccharide
(LPS)-induced microcirculatory injury. As so far, among 26
identified ginsenosides, Ginsenoside-Rb1, −Ro, −Rg1, −Rc,
and -Re are highly abundant. In particular, Ginsenoside
Rb1 makes up 0.37-0.5% of ginseng extracts [5]. Cell cul-
ture studies have shown that Ginsenoside Rb1 can inhibit
LPS-induced expression of the proinflammatory cytokine
TNF-α. We previously identified that Ginsenoside Rb1,
which is isolated from Notoginseng and Ginseng in
Chinese herbal medicine efficiently can attenuate LPS-
induced intestinal injury by inhibiting NF-κB activation
[6]. However, the effect of Ginsenoside Rb1 on lung micro-
circulatory injury has not been reported thus far.
Therefore, in the present study, we developed a rat
model of ALI induced by LPS, in vivo. Meanwhile, an
in vitro model of PMVECs was established to observe
the inflammatory injury induced by LPS. The goal of the
present study was to clarify the effects of Ginsenoside
Rb1 on LPS-induced rat lung injury and analyzed the
detailed molecular mechanisms in vivo and in vitro.Figure 1 Structures of Ginsenoside Rb1 (Rb1) major active componenMethods
Reagents and animals
Ginsenoside Rb1 was purchased from the National Institute
for the Control of Pharmaceutical and Biological Products.
The saponin was chromatographically pure, and the chem-
ical structure was shown in Figure 1.
LPS (E.coli LPS serotype 0111: B4), Endothelial Cell
Growth Supplement (ECGS), Fetal bovine serum (FBS)
were obtained from Sigma (St. Louis, MO, USA), mouse
anti-intercellular adhesion molecule-1 (ICAM-1) was pur-
chased from BD Pharmingen (San Diego, CA), rabbit anti-
myeloperoxidase (MPO) was purchased from NeoMarkers
(Fremont, CA, USA). Moloney Murine Leukemia Virus
(M-MLV) reverse transcriptase and Dulbecco’s modifica-
tion of Eagle’s medium Dulbecco (DMEM) were obtained
from Invitrogen (Carlsbad, CA, USA), rabbit anti-factor
VIII-related antigen, β-actin, anti-β-actin, anti-NF-κB p65
and ABC kit were obtained from Santa Cruz Biotechnology
Inc ( Santa Cruz, CA, USA).
All animals were handled according to the procedures
approved by the Committee on the Ethics of Animal Ex-
periments of Capital Medical University. This investigation
was carried out in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. All surgery
was performed under sodium pentobarbital anesthesia,
and all efforts were made to minimize suffering.
Experimental preparation
Male Wistar rats weighing 300 to 350 g were obtained
from the Animal Center of Capital Medical University.
The rats were fed a standard laboratory chow diet and
maintained at 24 ± 1°C, relative humidity of 50% ±1%
with a 12-h-12-h light–dark cycle. The animals werets of RG.
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cess to water.
Experimental protocol
According to the report, ALI was induced by intraven-
ous injection of LPS [7]. The rats were divided randomly
into three groups: Control group, LPS group and LPS +
Ginsenoside Rb1 group.
In the Control group, the 1 ml normal saline was ad-
ministered intravenously in 1 min, followed by continu-
ous intravenous injection of normal saline 4 ml/kg/h for
60 mins continuously (n = 10).
In the LPS group, LPS (100 ug/kg) dissolved in 1 ml sa-
line was administered intravenously in 1 min, the animals
were observed for 10 mins, then followed by intravenous
injection of normal saline at 4 ml/kg/h for 60 mins con-
tinuously (n = 10).
In the LPS + Ginsenoside Rb1 group, LPS (100 ug/kg)
dissolved in 1 ml saline was administered intravenously
in 1 min, the animals were observed for 10 mins, then
followed by intravenous injection of Ginsenoside Rb1 at
5 mg/kg/h for 60 mins continuously (n = 10). The dose
of Ginsenoside Rb1 was determined from the reports of
Sun etal [8].
Lung W/D ratio
The blood-free W/D ratio was determined as described
by Xie etal [9]. Briefly, the lung was homogenized with
an identical weight of distilled water. Homogenate and
blood samples were weighed and dried at 80°C for 48
hours. Dry weights were measured, and the W/D ratios
of the homogenate and blood were calculated. A sample
of the homogenate was centrifuged at 12,500 rpm for 1
hour, and blood samples were diluted with an equal vol-
ume of distilled water. To determine the Hb levels in the
homogenate and blood, 20 μl of the homogenate super-
natant or diluted blood was tested with a blood cell
analyzer (Cell-DYN 1700, Dainabot, Tokyo, Japan). The
weight of blood in the wet lung was then calculated. The
blood-free W/D ratio was then determined.
Historical and immunohistochemistry examination
The same rats were used for histological evaluation.
After the infusion of the reagents, the right upper lung
of each mouse was removed and fixed with 10% buffered
formalin. The samples were further processed as routine,
and mounted sections were stained with hematoxylin
and eosin for light microscopy. For immunohistochemis-
try, frozen sections of lung were acetone-fixed and then
incubated with 10% normal rabbit serum in PBS (10 mi-
nutes, 37°C) to block nonspecific staining. Sections were
then incubated with mouse anti-intercellular adhesion
molecule-1 (ICAM-1) or rabbit anti-myeloperoxidase
(MPO) overnight at 4°C, followed by incubation withbiotinylated donkey anti-rabbit or donkey anti-mouse
IgG (1:200) for 30 min. Positive staining was revealed by
diaminobenzidine, according to the manufacture’s in-
struction of the ABC kit. The number of MPO positive
cells was counted within a field of view under the micro-
scope with a 20 × objective lens and 5 fields were se-
lected randomly in each section with the Imaging-Pro
Plus 6.0.
Real-time reverse transcription-polymerase chain reaction
(RT-PCR)
Real-time RT-PCR analysis was performed as described
previously with some modifications [10,11]. Briefly, total
RNA was extracted from lung tissue as described above
and then poly(A) + RNA was isolated using Oligotex™
dT30 (Takara, Tokyo, Japan). The first-strand cDNA was
generated by reverse transcription reaction using MMLV
reverse transcriptase and the poly(A) + RNA prepara-
tions as templates. The cDNA was amplified by RT-PCR
by using a Light Cycler (Roche Diagnostics, Indianapolis,
IN) with the specific upstream and downstream primers
for ICAM-1 mRNA analysis under the following reac-
tion conditions: denaturation at 95°C for 10 mins,
followed by 40 cycles of denaturation at 95°C for 10 sec-
onds, annealing at 60°C for 10 seconds, and extension at
72°C for 8 seconds. The sequences of the upstream and
downstream primers for ICAM-1 and β-actin were as
follows: 5′-CAAACGGGAGATGAATGGTA-3′ and 5′-
AATAGGTGTAAATGGACGCC-3′ for ICAM-1; and
5′-CCTGTATGCCTCTGGTCGTA-3′ and 5′-CCATC
TCTTGCTCGAAGTCT-3′ for β-actin, respectively. The
product sizes were 176 bp for ICAM-1 and 260 bp for β-
actin, respectively. The amplified products were analyzed
by melting curve analysis and stained using SYBR GreenI.
The ICAM-1 mRNA level was normalized with the β-
actin mRNA level in each poly(A) + RNA preparation.
Relative gene expressions were calculated by using the
2−ΔΔCt method, in which Ct indicates cycle threshold,
the fractional cycle number where the fluorescent signal
reaches detection threshold [12]. The normalized ΔCt
value of each sample is calculated using up to an en-
dogenous control gene (β-actin). Fold change values are
presented as average fold change =2−(averageΔΔCt) for
genes in treated relative to control samples.
Transmission electron microscope
The fresh left upper lung tissues (2 × 2 × 2 mm) were
taken for electron microscopy. The specimen was fixed
in 2.5% glutaraldehyde and phosphate buffer. The speci-
men was then rinsed in phosphate buffer, postfixed with
1% osmic tetroxide in phosphate buffer. After graded de-
hydration in ethyl alcohol and propylene oxide, speci-
men was embedded in Spurr resin. Then, the embedded
tissues were thin-sectioned, mounted on copper grids,
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were taken by electron microscope (H-600IV, HITACHI,
Tokyo, Japan).
Peripheral blood TNF-α, MCP-1 and IL-8 assay
After the infusion, blood was collected via abdominal
aorta of each animal and anticoagulated with heparin
(20 unit/ml blood). The plasma was isolated by centri-
fugation. Fifty microliters of plasma or standard was
incubated with 50 μl capture beads for 1 h at room
temperature, and then mixed with 50 μl phycoerythrobi-
lin (PE)-labeled TNF-α, MCP-1 and IL-8 detection anti-
bodies and incubated for 2 h at room temperature to
form a sandwich complex. Following incubations, 1 ml
of washing buffer (BD, Biosciences Pharmingen, USA)
was added to each tube. The mean fluorescence inten-
sities of TNF-α, MCP-1 and IL-8 were measured by flow
cytometry (FACS Calibur, B.D. Co., USA) and the data
were analyzed by BD Cytometric Bead Array analysis
software.
Culture and identification of rat PMVECs
Rat PMVECs were isolated from peripheral parts of the
lung of Wistar rats, purified, and cultured as described
in Kim [13]. Briefly, Wistar rats were maintained under
specific pathogen-free and controlled light conditions
(22°C, 55% humidity, and 12-hour day/night rhythm).
After animals were died, the thoracic cavity was opened
and the lung was exposed fully, lung tissue was cut from
peripheral parts of the lung, pasted in culture flasks and
cultured in DMEM with 20% FBS, 50 lg/ml ECGS. Be-
hind cells emigrated from the pasting tissue and were
grown to confluence, cells were purified by different
speed adherence method. The cell morphology was ob-
served in inverted optical microscope. Primary rat pul-
monary microvascular endothelial cells (PMVECs) were
grown in a humidified atmosphere with 5% CO2. Experi-
mental data were obtained from cells in their third to
fifth generation. The immunocytochemical staining of
factor VIII-related antigen was to performed to identify
the PMVECs. The cells were fixed with 3.7% paraformal-
dehyde and permeabilized with 0.25% Triton X-100.
After rehydrating with 5% bovine serum albumin, the
cells were exposed to rabbit anti-factor VIII-related anti-
gen. On washing 3 times with PBS, they were exposed to
goat anti-rabbit IgG. The cells were then stained with
3,3′-diaminobenzidine and the negative control group
received only the secondary antibody [14]. The cells
were analyzed and identified under inverted microscope.
The protocol was approved by the Committee on the
Ethics of Animal Experiments of Capital Medical Uni-
versity. All surgeries were performed under sodium
pentobarbital anesthesia, and all efforts were made to
minimize suffering.PMVECs treatment and NF-κB p65 immunocytochemistry
staining
Cultured rat PMVECs were randomly divided into two
groups: Control group and LPS group. Cells in Control
group were received vehicle (0.01% DMSO) only. In LPS
group the cells were stimulated with 1000 ng/ml LPS
previously for 1 h. At the end of the stimulation, the
cells were treated with 50 mM Ginsenoside Rb1 or ve-
hicle (0.01% DMSO) for 4 h, respectively. To observe
the expression of NF-κB p65 on PMVECs, immunocyto-
chemistry staining was carried out as described previ-
ously. The cells were fixed with 3.7% paraformaldehyde
and permeabilized with 0.25% Triton X-100. After rehy-
drating with 5% bovine serum albumin, the cells were
exposed to rabbit anti- NF-κB p65. On washing 3 times
with PBS, they were exposed to goat anti-rabbit IgG.
The cells were then stained with 3,3′-diaminobenzidine
and the negative control group received only the second-
ary antibody. The cells were analyzed under inverted
microscope. Total and nuclear proteins were extracted
from cells to measure the NF-κB p65 at the end of
observation.Western blotting
The cells were washed twice with cold PBS. Then, cells
were lysed with SDS sample buffer containing 50 mM Tris
(pH 7.4), 2% SDS (wt/vol), 5% 2-mercaptoethanol and 10%
glycerol. Cell homogenates were centrifuged at 10,000 rpm
at 4°C for 60 min. Supernatants of cells were collected, and
protein concentration of each sample was measured with a
bicinchoninic acid assay kit using BSA as standard. An
equal amount of protein from each sample (150 mg) was
resolved in 10% Tris-glycine SDS polyacrylamide gel. Pro-
tein band was blotted to nitrocellulose membrane. After
incubation for 1 h in blocking solution (5% dry milk in Tris
buffered saline with Tween 20) at room temperature (RT),
the membrane was incubated for 24 h with anti-β-actin
(1:1000), anti-NF-κB p65 (1:800) at 4°C, respectively. The
secondary antibody (horseradish peroxidase-conjugated
donkey anti-rabbit immunoglobulin) was added at 1:10000
dilution and incubated at room temperature for 1 h. Perox-
idase labeling was detected with the enhanced chemilu-
minescence Western blotting detection system (Amersham
Pharmacia Biotech, Piscataway, NJ) and analyzed by a
densitometry system. The relative protein level was nor-
malized to β-actin.Statistical analysis
All values were presented as mean ± SE. For the remaining
parameters, the means of different groups were compared
by ANOVA and F-test. A value of P <0.05 was designed as
significant.
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Histologic examination of the lung and W/D ratio
We examined the effect of Ginsenoside Rb1 treatment on
lung injury after LPS infusion. Lung injury was assessed by
morphological examination, with the W/D ratio as an
index of pulmonary edema [15]. Sections of lung excised
from control animals were essentially normal (Figure 2A
top). In contrast, LPS animals exhibited serious alveolar
collapse, severe thickening of interalveolar septa with
marked infiltration of neutrophil (Figure 2A, middle).
Ginsenoside Rb1 treatment greatly suppressed lung injury,
and reduced histological damage (Figure 2A, bottom). The
W/D ratio of lung are shown in Figure 2B. The W/D ratio
was significantly higher in the LPS group than in the con-
trol (p < 0.05) and LPS (p < 0.05) groups. There was no sig-
nificant difference in the W/D ratio between the control
and Ginsenoside Rb1 groups. the marked decrease in lung
W/D ratio, which reached the same level as the control
animals (Figure 2B).
MPO-positive cells in the lung
As an indicative enzyme of neutrophil granulocytes, MPO
was revealed by immunohistochemical staining after LPS
infusion on lung to evaluate the leukocyte infiltration. The
representative images and the quantifications of the MPO-
positive cells in the three groups are presented in Figure 3.
The MPO-positive cells was hardly detectable in Con
group (Figure 3A top) but significantly increased by
LPS, indicative of leukocyte infiltration in this situation
(Figure 3A middle). Noticeably, the LPS elicited increaseFigure 2 The effect of Ginsenoside Rb1 on the histology of rat lung. A
on lung histologic changes. B. Effect of Ginsenoside Rb1 treatment on lung
Ginsenoside Rb1 group. Data were expressed as mean ± S.E of 10 animals.in MPO-positive cells was significantly inhibited by ad-
ministration of Ginsenoside Rb1 (Figure 3A, bottom).
ICAM-1 and gene expression in the lung
Since cell adhesion molecules play pivotal roles in pul-
monary inflammation by the recruitment of leukocytes
into the lung [16,17], immunohistochemical analysis of
ICAM-1 was carried out in the lung 60 mins after LPS in-
fusion. As noticed from Figure 4 rare expression of
ICAM-1 was detected on microvascular endothelium of
lung in Con group (Figure 4A, top). In contrast, the im-
munochemical staining for the expression of ICAM-1 was
prominent in LPS group (Figure 4A, middle), which was
attenuated significantly by treatment with Ginsenoside
Rb1 (Figure 4A, bottom). This result was confirmed by a
quantitative evaluation of the ICAM-1 mRNA level, which
was almost similar with immunohistochemical analysis.
The ICAM-1 mRNA level was detectable in Con group
whereas it was markedly increased in the LPS group. In
contrast, in LPS plus Ginsenoside Rb1 group the level was
significantly decreased to almost the same as that of the
Control group (Figure 4B).
Ultrastructure changes of pulmonary microvasculature
Figure 5 presents the electron micrographs of rat pul-
monary microvasculature in each group. In the Con
group (Figure 5A) microvasculature was lined by a layer
of endothelial cells, which exhibited a rather smooth
inner face with occasionally occurring vesicles in the
cytoplasm. At 60 min after LPS infusion, an apparent. Representative images for the effect of Ginsenoside Rb1 treatment
W/D ratio. Con: Control group; LPS: LPS group; LPS + Rb1: LPS plus
* P < 0.05 vs. Con group, # P < 0.05 vs. LPS group.
Figure 3 The effect of Ginsenoside Rb1 on the on the number of MPO-positive cells in rat lung. A. Representative images for the effect of
Ginsenoside Rb1 treatment on number of MPO positive cells in lung. B. Effect of Ginsenoside Rb1 treatment on number of MPO positive cells in
lung. Con: Control group; LPS: LPS group; LPS + Rb1: LPS plus Ginsenoside Rb1 group. Data were expressed as mean ± S.E of 10 animals. * P < 0.05 vs.
Con group, # P < 0.05 vs. LPS group.
Figure 4 The effect of Ginsenoside Rb1 on the expression of ICAM-1 and ICAM-1 mRNA on microvascular endothelium of lung.
A. Representative images for the effect of Ginsenoside Rb1 treatment on expression of ICAM-1. B. Effect of Ginsenoside Rb1 treatment on
expression of ICAM-1 mRNA in lung. Con: Control group; LPS: LPS group; LPS + Rb1: LPS plus Ginsenoside Rb1 group. Data were expressed as
mean ± S.E of 10 animals. * P < 0.05 vs. Con group, # P < 0.05 vs. LPS group.
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Figure 5 Representative electron micrographs of rat pulmonary microvasculature. A: Control group; B: LPS group; C: LPS plus Ginsenoside
Rb1 group. Arrow: intercellular junction. In the Con group microvasculature was lined by a layer of endothelial cells, which exhibited a rather
smooth inner face with occasionally occurring vesicles in the cytoplasm. An apparent alteration occurred in the ultrastructure of the endothelial
cell, characterized by the increase in the gap of intercellular junctions in LPS group.
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curred, characterized by the increase in the gap of inter-
cellular junctions (Figure 5B). LPS-induced alterations in
the ultrastructures of endothelial cell were abated by
treatment with Ginsenoside Rb1 (Figure 5C).Determination of concentration of inflammatory markers
in plasma
The concentrations of the cytokines TNF-α and MCP-1
in plasma are presented in Figure 6. In the Con group,
the concentrations of TNF-α, MCP-1 and IL-8 were
25.54 ± 5.64, 23.71 ± 8.17 and 45.12 ± 15.21 ng/l, respect-
ively. The concentrations of the two cytokines were en-
hanced dramatically by LPS stimulation to 495.87 ±
172.54, 745.63 ± 146.54 and 301.45 ± 89.12 ng/l, respect-
ively. Treatment with Ginsenoside Rb1 inhibited theFigure 6 The effect of Ginsenoside Rb1 on the inflammatory
markers concentration in plasma. Con: Control group; LPS: LPS group;
LPS + Rb1: LPS plus Ginsenoside Rb1 group. Data were expressed as
mean ± S.E of 10 animals. * P < 0.05 vs. Con group, # P < 0.05 vs.
LPS group.LPS-induced production of TNF-α, MCP-1 and IL-8
markedly (Figure 6).
Expression of NF-κB p65 in PMVECs
Activation of NF-κB pathway leads to phophorylation of
p50 and p65. Our investigation found a noticeable in-
creased expression of NF-κB p65 and its subsequent
translocation into the nucleus 60mins after LPS stimula-
tion in PMVECs (Figure 7A, middle), which was amelio-
rated by Ginsenoside Rb1, indicating that Ginsenoside
Rb1 inhibited the activation of NF-κB p65 (Figure 7A,
bottom). The expression of NF-κB p65 was quantified as
a parameter for NF-κB activation by Western blotting.
The results showed that the expression of NF-κB p65 in-
creased in the LPS group, similarly, this increase was sig-
nificantly inhibited by treatment with Ginsenoside Rb1
(Figure 7B-C).
Discussion
The present study demonstrated LPS infusion caused se-
vere lung injury with the characteristic features of ALI,
as revealed by the evidence of alveolar septal thickening
due to interstitial edema with infiltration of inflamma-
tory cells [18]. We also confirmed that Ginsenoside Rb1,
a main component of traditional Chinese herb RG, on
the LPS-induced lung injury and inflammation. The re-
sults in the present study demonstrated that Ginsenoside
Rb1 significantly attenuated the LPS-induced lung in-
jury, as shown by the lesser tissue injury compared with
that observed in the LPS animals, the W/D ratio, the ex-
pression of ICAM-1 along the vascular endothelium, the
mRNA level of ICAM-1, inflammatory factors, and NF-
κB p65 expression in the lung. These results suggest
that, Ginsenoside Rb1 may protect the lung from LPS-
induced tissue injury.
LPS is responsible for the initiation of the septic cas-
cade in Gram-negative bacterial infections, which in-
volves upregulation of ICAM-1 and production of large
Figure 7 The effect of Ginsenoside Rb1 on the activation of NF-κB p65 in PMVECs. A. Representative images for the effect of Ginsenoside
Rb1 treatment on activation of NF-κB p65 in PMVECs. B. Representative images of Western Blotting for the effect of Ginsenoside Rb1 treatment
on activation of NF-κB p65 in PMVECs. C. Effect of Ginsenoside Rb1 treatment on expression of NF-κB p65 in PMVECs. Con: Control group; LPS:
LPS group; LPS + Rb1: LPS plus Ginsenoside Rb1 group. Data were expressed as mean ± S.E of 10 animals. * P < 0.05 vs. Con group, # P < 0.05 vs.
LPS group.
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both mediated by NF-κB [21,22]. Because NF-κB activa-
tion can lead to enhanced expression of proinflammatory
cytokines (MCP-1, TNF-α), chemokines and adhesion
molecules, modulation of NF-κB activation may provide a
direct way of inhibiting inflammatory mediators.
LPS caused severe lung injury with the characteristic
features of ALI, as revealed by the evidence of alveolar
septal thickening due to interstitial edema with infiltration
of inflammatory cells [23] (Figure 2A, middle), which was
confirmed by the increase in lung W/D ratio. We have
previously reported that treatment with Yiqifumai, whose
main ingredient is RG, significantly attenuates LPS-
induced microcirculatory disturbance in rat mesentery
suggesting that Yiqifumai is a promising regime for treat-
ment of LPS-evoked sepsis thanks to its multiple targeting
potential for the initial steps of the process. The present
experiment demonstrate that Ginsenoside Rb1, the main
ingredient of RG, may be specifically capable of attenuat-
ing the LPS-induced lung injury.
It is known that the number of MPO-positive cells in
tissues is markedly relevant to tissue neutrophils accu-
mulation and served as an index of inflammation, be-
cause MPO is an enzyme that is released mainly from
neutrophils [24]. The endothelial permeability thus in-
creases due to the structure damage of the endothelial
cells as well as to the enzymatic cleavage of adherentjunction proteins [25], which eventually results in the
transmigration of leukocytes across the endothelial lin-
ing into the surrounding tissues and the loss of plasma
into extravascular space leading to severe hypoxemia
and life-threatening edema in the lung [26,27]. The re-
sult of the present research demonstrated that treatment
with Ginsenoside Rb1 reduced the accumulation of neu-
trophils in rat lung tissue exposed to LPS.
Histological examination and MPO assay in lung tis-
sue showed more extensive neutrophil infiltration in the
ALI group. Meanwhile, LPS is known to cause pulmon-
ary inflammation in association with neutrophil seques-
tration in the pulmonary microvasculature, followed by
adhesion and activation [28,29]. We therefore studied
the effects of Ginsenoside Rb1 on expression of the ad-
hesion molecule required for neutrophil recruitment in
lung tissue. Expression of ICAM-1, which is an import-
ant adhesion molecule for neutrophil activation, mark-
edly increased in the vascular endothelium after LPS
infusion [30]. The sepsis-associated organ injury is fur-
ther complicated by the implication of overproduction
of cytokines such as TNF-α, MCP-1 and IL-8, which are
believed to be pro-inflammatory factors, are produced
by activated monocyte/macrophages, and acts mainly to
attract neutrophils and monocytes [31]. These chemo-
kines are all associated with the influx, accumulation
and activation of highly destructive cells involved in
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Ginsenoside Rb1 significantly reduced excessive accu-
mulation of inflammatory cytokines in the peripheral
blood [32]. We have acquired the similar outcomes in
this study, Ginsenoside Rb1 alleviated remarkably the
overproduction of inflammatory markers (TNF-α, MCP-
1 and IL-8). In contrast, Ginsenoside Rb1 treatment
significantly attenuated the expression of these proinflam-
matory molecules compared with LPS infusion alone.
Thus, these findings suggest that Ginsenoside Rb1 pos-
sesses potent anti-inflammatory properties, and hence is
able to suppress LPS-induced pulmonary tissue inflam-
mation and injury. In line with these findings, the result
of electron microscopy in the present study showed the
gap of intercellular junctions apparently increased at 60
min after LPS infusion, whereas the endothelial cells
themselves remained intact with Ginsenoside Rb1 treat-
ment, implying that LPS-induced plasma leakage ob-
served in the present situation was mainly inhibited by
Ginsenoside Rb1.
However, it has been reported that LPS acts to up-
regulate the gene expression of IL-8, a proinflammatory
chemokine, through the IL-1 receptor-associated kinase
intracellular signaling pathway, resulting in the activation
of NF-κB [33]. In animal model, our results showed that
LPS injection markedly promoted NF-κB p65 phosphoryl-
ation [34]. In this study, LPS-induced over phosphorylated
NF-κB p65 was notably suppressed by Ginsenoside Rb1,
in vitro. These results demonstrated that the anti-
inflammatory property of Ginsenoside Rb1 was very likely
mediated by inactivation of NF-κB phosphorylation.
Conclusion
In this study, the beneficial effects found for Ginsenoside
Rb1 may be attributed at least in part to decrease of NF-
κB activity, which plays a crucial role in regulating the ex-
pression of proinflammatory molecules including TNF-α
and MCP-1. The molecular mechanism behind the pro-
tective effect of Ginsenoside Rb1 on the LPS-induced lung
injury is unclear and requires further identification, al-
though the advantage of using Ginsenoside Rb1 is evident.
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